Drug treatment of obesity: established and emerging therapies
| UDC.coleccion | Investigación | es_ES |
| UDC.departamento | Fisioterapia, Medicina e Ciencias Biomédicas | es_ES |
| UDC.endPage | 673 | es_ES |
| UDC.grupoInv | Enfermidades Endocrinas, Nutricionais e Metabólicas (INIBIC) | es_ES |
| UDC.grupoInv | Grupo Fisiopatoloxía Endócrina, Nutricional e Médica (FENM) | es_ES |
| UDC.institutoCentro | CICA - Centro Interdisciplinar de Química e Bioloxía | es_ES |
| UDC.institutoCentro | INIBIC - Instituto de Investigacións Biomédicas de A Coruña | es_ES |
| UDC.issue | 6 | es_ES |
| UDC.journalTitle | Mini-Reviews in Medicinal Chemistry | es_ES |
| UDC.startPage | 664 | es_ES |
| UDC.volume | 9 | es_ES |
| dc.contributor.author | Isidro, María Luisa | |
| dc.contributor.author | Cordido, Fernando | |
| dc.date.accessioned | 2025-04-11T06:37:39Z | |
| dc.date.available | 2025-04-11T06:37:39Z | |
| dc.date.issued | 2009 | |
| dc.description | Review | es_ES |
| dc.description.abstract | [Abstract] Available anti-obesity pharmacotherapy options remain very limited. The development of more effective drugs has become a priority. The potential strategies to achieve weight loss are to reduce energy intake, by stimulating anorexigenic signals or by blocking orexigenic signals, and to increase energy expenditure. This review will focus on approved obesity medications, as well as potential new pharmacological treatment options. | es_ES |
| dc.identifier.citation | Isidro ML, Cordido F. Drug treatment of obesity: established and emerging therapies. Mini Rev Med Chem. 2009 Jun;9(6):664-73. | es_ES |
| dc.identifier.doi | 10.2174/138955709788452739 | |
| dc.identifier.issn | 1389-5575 | |
| dc.identifier.uri | http://hdl.handle.net/2183/41708 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | Bentham Science | es_ES |
| dc.relation.uri | https://doi.org/10.2174/138955709788452739 | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.subject | Obesity | es_ES |
| dc.subject | Drug treatment | es_ES |
| dc.subject | Orlistat | es_ES |
| dc.subject | Sibutramine | es_ES |
| dc.subject | Rimonabant | es_ES |
| dc.subject | Leptin | es_ES |
| dc.subject | Ghrelin | es_ES |
| dc.title | Drug treatment of obesity: established and emerging therapies | es_ES |
| dc.type | review | es_ES |
| dc.type.hasVersion | AM | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | df28f954-c072-4ef1-b629-d6af3945bd92 | |
| relation.isAuthorOfPublication.latestForDiscovery | df28f954-c072-4ef1-b629-d6af3945bd92 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Isidro_Drug_2009.pdf
- Size:
- 442.34 KB
- Format:
- Adobe Portable Document Format
- Description:

